Tag: US plasma fractionation market

  • How Will the Plasma Fractionation Market Grow? Key Trends and Opportunities for 2025 and Beyond

    How Will the Plasma Fractionation Market Grow? Key Trends and Opportunities for 2025 and Beyond

    Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

    How Will the Plasma Fractionation Market Grow Over the Forecast Period Based on Its Expected CAGR?

    The market of plasma fractionation has seen a robust increase in its size over the last few years. The market, which was valued at $31.42 billion in 2024, is projected to grow to $34.44 billion in 2025, with a compound annual growth rate (CAGR) of 9.6%. The historic growth in this market is due to factors such as a rise in cases of hemophilia and immunodeficiency disorders, larger aging population, increased demand for immunoglobulins, expansion of plasma collection facilities, and an increase in the number of surgical procedures.

    In the upcoming years, the plasma fractionation market is projected to experience a swift expansion. By 2029, it is expected to upsurge to $51.56 billion, with a Compound Annual Growth Rate (CAGR) of 10.6%. This growth during the projection period can be associated with factors such as an increase in worldwide health expenses, the rising use of plasma-based medical products, greater investments into research and development, the need for plasma in treating neurological diseases and the broadening of plasma fractionation facilities. Leading trends expected during this period are the creation of new fractionation technologies, a move towards albumin and immunoglobulin therapies, growing demand for distinctive plasma products, focus on pathogen inactivation technologies, and strategic affiliations and partnerships within the plasma industry.

    Which Factors Are Enhancing the Growth of the plasma fractionation Market?

    The plasma fractionation market is predicted to grow due to the escalating prevalence of chronic diseases. Chronic diseases, such as heart ailment, cancer and diabetes, are long-term conditions necessitating continuous medical supervision. The application of plasma products in treating these chronic diseases not only curtails the rate of morbidity but also enhances life quality and is economically viable, thereby escalating the demand for plasma fractionation. For example, a National Library of Medicine report in January 2023 indicated that the US population aged 50 and above suffering from one or more chronic diseases would increase by 99.5%, reaching 142.66 million by 2050, a significant rise from 71.522 million in 2020. Consequently, the surge in chronic diseases is stimulating the growth of the healthcare analytical testing service market. Hence, the plasma fractionation market is projected to grow owing to the enhanced prevalence of chronic diseases across all ages.

    Explore Comprehensive Insights Into The Global Plasma Fractionation Market With A Free Sample Report:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=7543&type=smp

    Who Are the Dominant Players Expanding Their Reach in the Plasma Fractionation Market?

    Major companies operating in the plasma fractionation market include:

    • Baxter International Inc._x000D_

    • Bio Products Laboratory Limited_x000D_

    • Biotest AG_x000D_

    • CSL Limited_x000D_

    • Grifols S. A_x000D_

    What Are the Top Trends Shaping the Evolution of the Plasma Fractionation Market?

    Leading businesses present in the market are utilizing innovative technologies like hi-tech facility processes to turn donated human plasma into essential drugs. They are also employing more sophisticated technological systems to bolster the efficiency and safety of these processes. This was evidenced by CSL Behring, a German-based firm that inaugurated a new plasma fractionation facility worth $470 million in March 2023. This facility leverages state-of-the-art technology to elevate the efficiency and safety standards of plasma processing, resulting in higher quality and more dependable drugs. The facility aids in accommodating the soaring demand by augmenting the supply of these vital medicines, thereby ensuring broader accessibility of life-saving remedies for patients. The inclusion of advanced automation and self-cleaning systems minimizes contamination risks and enhances overall hygiene, thereby upraising patient safety.

    Secure Your Global Plasma Fractionation Market Report Now for Fast and Efficient Delivery!

    https://www.thebusinessresearchcompany.com/report/plasma-fractionation-global-market-report

    Which Segments of the Plasma Fractionation Market Hold the Most Potential for Future Development?

    The plasma fractionation market covered in this report is segmented –

    1) By Product: Immunoglobulins, Coagulation Factors, Albumin, Protease Inhibitors

    2) By Application: Immunology, Hematology, Neurology, Critical Care, Hemato-Oncology, Rheumatology

    3) By End User: Hospitals and Clinics, Clinical Research Laboratories, Academic Institutes

    Subsegments:

    1) By Immunoglobulins: Intravenous Immunoglobulin (IVIG), Subcutaneous Immunoglobulin (SCIG)

    2) By Coagulation Factors: Factor VIII, Factor IX, Prothrombin Complex Concentrates (PCC)

    3) By Albumin: Human Albumin, Bovine Serum Albumin (BSA)

    4) By Protease Inhibitors: Alpha-1 Antitrypsin (AAT), C1 Esterase Inhibitor (C1-INH)

    Which Regions Are Setting the Pace for Plasma Fractionation Market Growth?

    North America was the largest region in the plasma fractionation market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the plasma fractionation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    How Is the Plasma Fractionation Market Defined Across Different Regions?

    Plasma fractionation refers to the process of integrating manufacturing procedures to isolate the crude fractions that are then refined into specific medicinal products, in a sequential and integrated manner.

    Browse Through More Similar Reports By The Business Research Company:

    Blood And Blood Components Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/blood-and-blood-components-global-market-report

    Porcine Plasma Feed Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/porcine-plasma-feed-global-market-report

    Blood Transfusion Diagnostics Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/blood-transfusion-diagnostics-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • 2024 Plasma Fractionation Market Overview: Key Insights on Size, Share, and Trends

    2024 Plasma Fractionation Market Overview: Key Insights on Size, Share, and Trends

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    What is the Anticipated Growth Speed of the Plasma Fractionation Market Between 2024 and 2033?

    The plasma fractionation market will grow from $28.95 billion in 2023 to $31.78 billion in 2024, at a CAGR of 9.8%. The growth is driven by the growing prevalence of hemophilia and immunodeficiency disorders, an increasing aging population, rising demand for immunoglobulins, the expansion of plasma collection centers, and the growing number of surgical procedures.

    The plasma fractionation market is expected to reach $46.72 billion by 2028 at a CAGR of 10.1%. Growth is driven by global healthcare expenditure, rising applications of plasma-derived products, increased R&D investments, and a growing demand for plasma in treating neurological disorders. Key trends include new fractionation technologies, the shift towards albumin and immunoglobulin therapies, rising demand for specialty plasma products, pathogen inactivation technologies, and strategic collaborations in the industry.

    Claim Your Free Sample of the Global Plasma Fractionation Market Report Today!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=7543&type=smp

    Which Factors Are Enhancing the Growth of the plasma fractionation Market?

    The plasma fractionation market is poised for growth with the increasing number of chronic diseases. Chronic illnesses, lasting one year or more, are projected to affect a significant portion of the global population by 2050. Treating chronic diseases with plasma products enhances the quality of life and reduces morbidity, contributing to the rising demand for plasma fractionation and driving market growth.

    Which Segments Are Crucial in the Plasma Fractionation Market?

    1) By Product: Immunoglobulins, Coagulation Factors, Albumin, Protease Inhibitors

    2) By Application: Immunology, Hematology, Neurology, Critical Care, Hemato-Oncology, Rheumatology

    3) By End User: Hospitals and Clinics, Clinical Research Laboratories, Academic Institutes

    What Emerging Trends Are Shaping the Future of the 177 Market?

    Technological advancements are driving trends in the plasma fractionation market, with major companies introducing innovations like HYCON, a self-cleaning and fully automatic separator, to maintain their market position. GAE, a Germany-based pharmaceutical systems manufacturer, launched HYCON in June 2021. This fully automatic separator facilitates one-touch production for blood plasma and plasma proteins separation in clean room environments, enhancing hygienic conditions, preventing cross-contamination, and ensuring batch safety.

    Order Now for Fast Delivery of Your Plasma Fractionation Market Report!

    https://www.thebusinessresearchcompany.com/report/plasma-fractionation-global-market-report

    What Regions Are At the Forefront of Plasma Fractionation Market Expansion?

    North America was the largest region in the plasma fractionation market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the plasma fractionation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    The Plasma Fractionation Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the plasma fractionation market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The Plasma Fractionation Market Include

    1. Plasma Fractionation Market Executive Summary

    2. Plasma Fractionation Market Segments

    3. Plasma Fractionation Market Size And Template Market Growth Rate

    4. Key Plasma Fractionation Market Trends

    5. Major Plasma Fractionation Market Drivers

    ……

    25. Key Mergers And Acquisitions In The Plasma Fractionation Market

    26. Top Plasma Fractionation Companies

    27. Plasma Fractionation Market Opportunities And Strategies

    28. Plasma Fractionation Market, Conclusions And Recommendations

    29. Appendix

    Discover Related Reports by The Business Research Company:

    Wireless POS Terminal Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/wireless-pos-terminal-global-market-report

    Contactless Payment Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/contactless-payment-global-market-report

    Global Real-Time Payments Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/real-time-payments-global-market-report

    Learn More About The Business Research Company

    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • What’s The Growth Forecast For Plasma Fractionation Market Through 2024-2033?

    What’s The Growth Forecast For Plasma Fractionation Market Through 2024-2033?

    The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

    Rapid Expansion in Market Size

    The plasma fractionation market has witnessed robust growth, surging from $28.95 billion in 2023 to $31.78 billion in 2024, reflecting a commendable compound annual growth rate (CAGR) of 9.8%. This upward trajectory is fueled by several factors, including the rising prevalence of hemophilia and immunodeficiency disorders, an increasing aging population, growing demand for immunoglobulins, the expansion of plasma collection centers, and a surge in surgical procedures.

    Anticipating Further Surge

    The optimistic outlook continues into the forecast period, with the market poised to reach $46.72 billion in 2028 at a CAGR of 10.1%. This anticipated growth is attributed to the escalating global healthcare expenditure, expanding applications of plasma-derived medicinal products, heightened investments in research and development, the rising demand for plasma in treating neurological disorders, and the expansion of plasma fractionation facilities.

    Key Trends in the Forecast Period

    1. New Fractionation Technologies:The market is witnessing the development of innovative fractionation technologies.
    2. Shift towards Albumin and Immunoglobulin Therapies:There is a noticeable trend towards therapies utilizing albumin and immunoglobulins.
    3. Rising Demand for Specialty Plasma Products:Specialized plasma products are gaining traction, reflecting evolving patient needs.
    4. Focus on Pathogen Inactivation Technologies:Ensuring safety through pathogen inactivation technologies is a priority.
    5. Strategic Collaborations and Partnerships:Industry players are actively engaging in collaborations and partnerships, shaping the future of the plasma industry.

    Elevated Demand Driven by Chronic Diseases

    The increasing burden of chronic diseases is a significant driver for the heightened demand in the plasma fractionation market. As the number of individuals with chronic illnesses rises, reaching 142.66 million by 2050 in the United States alone, the demand for plasma products as a cost-effective and quality-improving treatment option is set to soar. Major players contributing to this growth include Baxter International Inc., CSL Limited, Grifols S. A, and many others.

    View More On The Plasma Fractionation Market Report 2024 – https://www.thebusinessresearchcompany.com/report/plasma-fractionation-global-market-report

    Revolutionizing Through Technological Advancements

    Technological advancements play a pivotal role in shaping the plasma fractionation market. Companies are introducing cutting-edge technologies such as HYCON, a fully automatic separator with self-cleaning capabilities. This not only improves hygienic conditions but also enhances cross-contamination prevention and batch safety. Such innovations contribute to the sustained growth and competitiveness of market participants.

    Grifols’ Strategic Move Enhancing Global Presence

    In April 2022, Grifols S. A. acquired Biotest AG for $317.03 million, a move aimed at revolutionizing plasma medicine availability. This strategic acquisition enables Grifols to expand its product line, own a vast network of plasma facilities, accelerate research and development projects, and achieve a more balanced revenue and supply distribution across geographies.

    Market Segmentation Insights

    1. By Product:The market is segmented into Immunoglobulins, Coagulation Factors, Albumin, and Protease Inhibitors.
    2. By Application:Segments include Immunology, Hematology, Neurology, Critical Care, Hemato-Oncology, and Rheumatology.
    3. By End User:The market caters to Hospitals and Clinics, Clinical Research Laboratories, and Academic Institutes.

    Regional Dynamics

    1. North America:Emerged as the largest region in 2023.
    2. Asia-Pacific:Expected to be the fastest-growing region in the forecast period.

    In conclusion, the plasma fractionation market is experiencing a transformative phase, marked by substantial growth, technological advancements, and strategic acquisitions. With the rise in chronic diseases, evolving therapies, and a focus on innovation, the market is poised for a promising future. Stakeholders, including major companies and investors, are actively shaping this dynamic landscape, anticipating a surge in demand and technological evolution in the coming years.

    Request A Sample Of The Global Plasma Fractionation Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=7543&type=smp